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Abstract 
Current international and national prophy-
lactic antibiotic regimens have been analyzed
in respect of the prevention of bacteremia after
dental and surgical procedures and, therefore,
of joint prosthesis infection. This information
was  used  to  formulate  guidelines  for  the
Department of Maxillofacial and Oral Surgery.
Publications  since  2003  were  used  in  this
research.  In  addition,  recommendations  of
accredited institutions and associations were
examined.  These  included  the  guidelines  of
the American Dental Association in associa-
tion  with  the  American  Academy  of
Orthopaedic  Surgeons  (2003),  the  American
Heart Association (2007), the Working Party of
the  British  Society  for  Antimicrobial
Chemotherapy  (2006)  and  the  Australian
Dental Guidelines (2005). No guidelines pub-
lished by any institution in South Africa were
found.  The  general  rationale  for  the  use  of
antibiotic prophylaxis for surgical (including
dental) interventions is that those procedures
may  result  in  a  bacteremia  that  may  cause
infection in joint prostheses. Antibiotics, how-
ever, should therefore be administered to sus-
ceptible  patients,  e.g.  immunocompromised
patients,  prior  to  the  development  of  bac-
teremia. The guidelines recommended for use
in South Africa are based solely on those used
outside South Africa. South Africa is regarded
as a developing country with its own popula-
tion and demographic characteristics. Eleven
percent of our population is infected with HIV,
and a specific guideline for prophylactic antibi-
otic treatment is, therefore, essential.
Introduction
There are many controversies in the dental
literature  regarding  the  use  of  prophylactic
antibiotics in patients with joint prostheses.
Antibiotics are prescribed in dentistry to treat
and prevent infections.
1
For  the  purpose  of  this  article,  the  main
indications and controversies relating to pro-
phylactic use of antibiotics in dentistry will be
reviewed, notably the prevention of bacteremia
and infections in patients with joint prosthe-
ses.
In the early 1950s, the first hip prosthesis
was  used  and  from  these  small  beginnings,
joint replacement has expanded to include the
knee, ankle, shoulder, elbow and finger joints.
Generally  these  joint  replacements  are  suc-
cessful with an over 90% success rate over a
10-year period.
2 In the United States in 1995,
243,919  total  knee  replacements  were  per-
formed
2 and  in  2003,  approximately  450,000
total joint arthroplasties were performed.
3,4 In
Australia, in the financial year 2002-2003, a
total of 55,836 total hip and knee replacements
were performed.
5 In Norway 73,000 arthroplas-
ties were performed between 1994 and 1999,
i.e. in 11 years.
6
Currently no register exists in South Africa
on  the  total  of  any  arthroplasties  performed
locally although many joint replacements were
performed in government and private hospi-
tals. The provision of joint prostheses is thus a
common orthopedic procedure.
In the late 1950s and early 1960s, there was
a high prevalence (15-25%) of post-operative
infections  associated  with  such  surgery.
1
Infections that occurred within three months
of surgery were categorized as early and were
related  to  the  surgical  procedure  either
sourced from the patient or the surgical staff.
1
Many  advances  have  been  made  across  the
world to minimize infection. Theatre design
incorporating laminar flow, improved surgical
technique, wearing of exhaust suits and pro-
phylactic antibiotics have all been shown to be
successful  at  limiting  infection  rates.  Many
countries  in  the  world,  such  as  France  and
Malaysia, have devised strict national guide-
lines to minimize discrepancies between hos-
pitals  and  improve  prophylactic  antibiotic
administration.
7 Infections after three months
of  surgery  were  considered  as  late  and  we
believed these to be caused by hematogenous
spread of bacteria from another site of infec-
tion elsewhere in the body.
1 The incidence of
this is low and in the order of 0.97%.
8Antibiotic
prophylaxis at the time of surgery reduced the
prevalence  of  post-operative  infection  to
approximately 1%.
1
Can  orthopedic  implants  be  infected  by
blood-borne  bacteria?  Historically  it  was
believed that one of the key sources of focal
infection was the teeth.
9 The basis of this the-
ory was the process of anachoresis which is
the preferential deposit of bacteria that have
localized out of the bloodstream into areas of
inflammation.
10 Today we know oral bacteria
clearly do enter the bloodstream during chew-
ing,  teeth  clenching  and  tooth  brushing,
although the amounts are small and transient.
The greatest amount of bacteremia occurs fol-
lowing  extraction  of  erupted,  periodontally
involved teeth.
9
The prevalent bacteria causing late infec-
tion  are  Staphylococcus  aureus (35%)  and
Staphylococcus epidermis (15%). These have a
skin origin.
11,12 Both infective endocarditis and
hematogenous total joint infection have been
documented to occur secondary to cutaneous
infections,  which  may  account  for  approxi-
mately one half of all late-onset hematogenous
total joint infections.
13 Group A Streptococci,
which are mainly from oropharyngeal origin,
occurred  in  about  8%  of  cases.  Thus  bac-
teremia-related joint infections of oral origin
may occur but generally at a low incidence.
Skin  organisms  are  the  predominant  group.
The risk of oral-related infections is very low
(0.04-0.07%).
11,12 There  is  extensive  soundly-
based  scientific  literature  on  this.
2,5,14-16 It  is
important that all papers which set out to doc-
ument  joint  infections  have  meticulous
methodology as it is easy for the source of the
infection to be based on anecdote. Ideally, to
confirm  that  an  implant  has  been  infected
from an oral treatment, one requires a coinci-
dent history and an accurate and simultaneous
typing of the oral flora bacteremia and joint
organisms.
14 These steps have not usually been
taken in most investigations in the literature
and some papers are based solely on history
9 of
dental treatment received before the arthro-
plasty procedure. There is scant evidence to
suggest  that  dental-induced  bacteremia  can
cause hematogenous infection around a pros-
thetic  joint.
15 By  contrast,  there  are  several
studies that show the opposite. Studies were
reported where late hematogenous joint infec-
tions in prosthetic joints occurred after dental
treatment. The organisms cultured from the
sites of infection were the same in both the
prosthetic joint and the oral cavity.
17-19 Other
articles were unable to demonstrate any case
of secondary joint infection after dental treat-
ment in a patient who was not medically com-
promised. Even in a healthy patient with joint
infection  there  was  not  enough  evidence  to
link  the  infection  to  dental  treatment.
20-23
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Infections of total hip or knee replacements
because  of  hematogenous  seeding  following
dental intervention are very rare. The scientif-
ic rationale for the use of systemic or local
antimicrobial  prophylaxis  to  prevent  bac-
teremia, is very weak at best.
24 The statement
that  there  is  no  evidence  to  link  prosthetic
joint infections to dental procedures and none
to prove that antibiotic is effective to prevent
bacteremia  was  also supported by Gould in
2008.
25 The  National  institute  of  Health  and
Clinical Excellence (NICE) made new recom-
mendations  available.  Antibiotic  prophylaxis
does not eliminate bacteremia following dental
procedures but some studies show that it does
reduce  the  frequency  of  detection  of  bac-
teremia post procedure. Therefore, they rec-
ommend that no prophylaxis is necessary for
prevention of infective endocarditis for dental
procedures. It is also not possible to determine
the effect of antibiotic prophylaxis on the dura-
tion  of  bacteremia.
26 The  whole  issue  of
chemoprophylaxis  in  dental  practice  is  sur-
rounded by a distinct lack of evidence based
information.  For  a  variety  of  justifiable  rea-
sons, there is a lack of randomized placebo-
controlled trials to determine the efficacy of
chemoprophylaxis in the various at-risk cate-
gories of patients. In many instances, the need
for antibiotic cover is driven by the medical
profession and is overstated.
27
All surfaces of the body are colonized by a
unique  micro  flora.  Any  bacteremia  may  be
caused by incision of the skin, gastroenteral
mucosa, airway mucosa, genitourinary mucosa
or oral mucosa. Bacteria from these sources
frequently enter the blood on a physiological
basis as a transient bacteremia and are dealt
with by the host defences.
28
Oral  bacteria  clearly  do  enter  the  blood-
stream during chewing, teeth clenching and
tooth brushing although the amounts are small
and transient.
29 Transient bacteremia that fol-
low normal activities such as chewing are usu-
ally cleared by the host defences within ten
minutes.
30 Oral interventions including dental
treatment will produce a greater bacteremia
than  physiological  function  but  is  of  a  low
grade  and  duration.  Even  a  simple  dental
extraction in a patient with chronic periodon-
titis will result in a greater bacterial load than
in a patient with optimal oral hygiene (Table
1).
31 Dental procedures can be classified into
high- and low-risk, based on the levels of bac-
teremia (Table 2).
3,32
Traditionally, ‘significant bleeding’ associat-
ed with a dental procedure has being equated
with a bacteremia. A recent study measuring
pre-  and  post-procedure  bacteremia  showed
that bleeding was a poor predictor of odonto-
genic  bacteremia  above  usual  physiological
levels.
33
The rationale for the use of antibiotic pro-
phylaxis for surgical, including dental, inter-
ventions  is  that  the  procedure  causes  bac-
teremia and the bacteremia may cause infec-
tion. Therefore it is reasoned that the antibi-
otics should be given to susceptible patients
before the bacteremia is induced.
28 Antibiotics
may prevent infection either by killing bacte-
ria or by damaging them to an extent in which
the host defences can then destroy them,
28 but
no randomized, placebo-controlled study has
established whether any of the antibiotic reg-
imens  recommended  are  efficacious.
27
General  preventive  measures  (good  dental
care and skin hygiene, avoidance of unneces-
sary procedures and  instrumentation) remain
essential.
28
Any  dose  of  oral  penicillin  can  cause  an
allergic reaction rate similar to that of intra-
muscular penicillin.
34 Hypersensitive patients
receiving penicillin prophylaxis to prevent bac-
teremia are five times more likely to die from
an anaphylactic reaction to the drug than to
die from contracting endocarditis.
1,35 It would
thus seem from these statistics that the risk of
providing antibiotic coverage to prevent bac-
teremias is far greater than those of not pro-
viding coverage?
Review
Table 1. Prevalence of bacteremia after dental procedures.
31
Procedure Prevalence of bacteremia
Extractions (single) 51%
Extractions (multiple) 68-100%
Endodontics (intra-canal instrumentation) 0-31%
Endodontics (extra-canal instrumentation) 0-54%
Periodontal surgery (flap procedure) 36-88%
Periodontal surgery (gingivectomy) 83%
Scaling and root planning 8-80%
Periodontal prophylaxis 0-40%
Tooth brushing 0-26%
Dental flossing 20-58%
Interproximal cleaning with toothpicks 20-40%
Irrigation devices 7-50%
Chewing 17-51%
Table 2. Incidence stratification of bacteremic dental procedures.
3,32
Incidence  Dental procedure
Higher  Dental extractions
incidence
† Periodontal procedures, including surgery, subgingival placement of antibiotic 
fibres/strips, scaling and rootplaning, probing, recall maintenance
Dental implant placement and replantation of avulsed teeth
Endodontic instrumentation beyond the apex
Endodontic surgery
Placement of retraction cord
Initial placement of orthodontic bands but not brackets
Intraligamentary and intraosseous local anesthetic injections
Prophylactic cleaning of teeth or implants where bleeding is anticipated
Lower  Restorative dentistry
¶ (operative and prosthodontic) with/without retraction cord
incidence
‡§ Local anesthetic injections
Intracanal endodontic treatment, post placement and build-up
Placement of rubberdam
Post-operative suture removal
Placement of removable prosthodontic/orthodontic appliances
Taking of oral impressions
Fluoride treatments
Taking of oral radiographs
Orthodontic appliance adjustment
†Prophylaxis should be considered for patients with total joint replacement who meet the criteria in Table 3. No other patients with
orthopedic implants should be considered for antibiotic prophylaxis prior to dental treatment / procedures. 
‡Prophylaxis not indicat-
ed. 
§Clinical judgement may indicate antibiotic use in selected circumstances that may create significant bleeding . 
¶Includes restora-
tion of carious (decayed) or missing teeth.‡ not indicated§ Clinical judgement may indicate antibi-
oticcarious (decayed) or missing teeth[page 24] [Orthopedic Reviews 2009; 1:e7]
Guidelines
Patients,  especially  immunocompromised
patients, who are about to have a total joint
arthroplasty should be in good dental health
prior to surgery and should be encouraged to
seek  professional  dental  care  if  necessary.
Patients  who  have  already  had  a  total  joint
arthroplasty  should  perform  effective  daily
oral hygiene procedures to remove plaque and
to establish and maintain good oral health.
3
The risk of bacteremia is far more substantial
in a mouth with ongoing inflammation than in
one that is healthy.
36
Bacteremia can cause hematogenous seed-
ing of total joint implants, both in the early
post-operative period and for many years fol-
lowing impantation.
37 It appears that the most
critical period is up to two years after implan-
tation.
38 Presently, no scientific evidence sup-
ports the position that antibiotic prophylaxis
to  prevent  hematogenous  infections  is
required prior to dental treatment in patients
with total joint prosthesis.
36
Antibiotic prophylaxis is not indicated for
dental patients with pins, plates and screws,
nor is it routinely indicated for most dental
patients  with  total  joint  replacement.
Antibiotic  prophylaxis  may  be  considered
when the higher-risk dental procedures (Table
2)  are  performed  on  dental  patients  within
two years post–implant surgery, on those who
have had previous prosthetic joint infections
and  on  those  with  some  other  conditions
(Table  3).
3 This  position  agrees  with  that
taken  by  the  ADA  Council  on  Dental
Therapeutics
39 and the American Academy of
Oral Medicine
40 and is similar to that taken by
the British Society for Antimicrobial Chemo-
therapy.
41
There  is  limited  evidence  that  some
immunocompromised patients with total joint
replacements (Table 3) may be at higher risk
of experiencing hematogenous infections.
42-49
Antibiotic prophylaxis for such patients under-
going  dental  procedures  with  higher  bac-
teremia risk should be considered using an
empirical  regimen  (Table  4).  In  addition,
antibiotic  prophylaxis  may  be  considered
when the higher-risk dental procedures (Table
2)  are  performed  on  dental  patients  within
two years post-implant surgery,
37 on those who
have had previous prosthetic joint infections
and  on  those  with  some  other  conditions
(Table 3).
3 Antibiotic prophylaxis is warranted
in three groups of patients with a prosthetic
joint who must undergo an invasive procedure
that could cause bacteremia: patients with a
predisposing immunocompromising systemic
condition or those receiving immunosuppres-
sive  therapy,  patients  with  a  dermatological
infection, and patients with an obvious focal
infection, e.g., urosepsis.
50
Conclusions
It  is  generally  accepted  that  all  patients
undergoing  joint  replacement  should  main-
tain good oral hygiene
51-53 and be dentally fit,
thus without any existing infection in the oral
cavity. This should be confirmed by a dentist
after full oral examination and radiographs.
The common situation of the orthopedic sur-
geon  asking  the  patients  if  their  teeth  are
“OK” is not enough. A patient can be unaware
of a painless condition like chronic periodon-
titis  or  chronic  tooth-abscess  which  may
arguably be a focus of infection. Patients who
have  already  had  a  total  joint  arthroplasty
should  perform  effective  daily  oral  hygiene
procedures to remove plaque (for example, by
using manual or powered toothbrushes, inter-
dental cleaners or oral irrigators) to establish
and  maintain  good  oral  health.  The  risk  of
bacteremia is far more substantial in a mouth
with ongoing inflammation than in one that
is  healthy  and  employing  these  home  oral
hygiene devices. Dental treatment in the pre-
implantation phase should be aggressive to
eliminate current foci of infection. If the con-
dition cannot be rapidly resolved by restora-
tive, endodontic or periodontal treatment the
involved teeth should be extracted. Antibiotic
prophylaxis would not usually be required for
such pre-implantation treatment. In the ini-
tial phase following placement of a joint pros-
thesis, dental treatment would not normally
be required if the patients have been made
dentally  fit  prior  to  the  procedure.  The
patients in this first three-month phase after
receiving  a  prosthetic  joint  are  usually  in
some orthopedic discomfort and are not usu-
ally  sufficiently  mobile  for  routine  dental
treatment.
The  guidelines  recommended  for  use  in
South Africa are based solely on those used
outside South Africa. South Africa is regarded
as a developing country with its own popula-
tion and demographic characteristics. Eleven
percent  of  our  population  is  infected  with
HIV
54,55 which  make  them  immunocompro-
mised.  The  clinician  is  not  always  fully
informed about the HIV-status of the patient.
Therefore  administration  of  antibiotic  pro-
phylaxis must be considered within the two
years after joint replacement to all patients.
Specific guidelines for prophylactic antibiotic
treatment to prevent a bacteremia are, there-
fore, essential for South Africa.
Review
Table 3. Patients at potential increased risk of experiencing hematogenous total joint
infection.
3
Patient type Risk condition
All patients during first two years following  N/A
†
joint replacement
Immunocompromised/suppressed patients Inflammatory arthropathies such as
rheumatoid arthritis, systemic lupus
erythematosus
Drug- or radiation-induced
immunosuppression
Previous prosthetic joint infections
Malnourishment  
Patients with comorbidities
‡ Hemophilia
HIV infection
Insulin-dependent (type 1) diabetes mellitus 
Malignancy 
†N/A: Not applicable; ‡ Conditions shown for patients in this category are examples only; there may be additional conditions that
place such patients at risk of experiencing hematogenous total joint infection.
Table 4. Suggested antibiotic prophylaxis regimens.
3
Patient type Suggested drug Regimen
Patients not allergic to penicillin Cephalexin, cephradine  2 g
† orally 1h prior to dental 
or amoxicillin procedure
Patients not allergic to penicillin  Cefazolin or ampicillin Cefazolin 1g or ampicillin
and unable to take oral medication 2 g intramuscularly or 
intravenously 1h prior to 
the dental procedure
Patients allergic to penicillin Clindamycin 600 mg orally 1h prior to 
the dental procedure
Patients allergic to penicillin and  Clindamycin 600 mg intravenously 
unable to take oral medications 1h prior to the dental procedure*
†There is evidence that 2 g is equivalent to 3 g oral amoxicillin with less risk of nausea.
46 *No second doses are recommended for any
of these dosing regimens.[Orthopedic Reviews 2009; 1:e7] [page 25]
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